Nasdaq
$27.15▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.03BShares out 37.9M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
44- 10.2After-hours26.10.03 06:194Ownership#●●●
Ceribell, Inc.
Raymond Woo, an insider at Ceribell, Inc., filed a Form 4 report regarding changes in beneficial ownership of securities as of October 1, 2026. This filing serves as a standard disclosure of equity transactions by a company executive or major shareholder.…more
$27.15+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.1Regular26.10.01 23:45144Ownership
Ceribell, Inc.
Insider Woo Raymond of Ceribell, Inc. has filed an SEC Form 144 to report a proposed sale of company securities. This is a standard filing disclosing the insider's plan to dispose of shares.…more
$27.15+0.00%vs prev closeView filingShare - 9.18Overnight26.09.18 09:454Ownership
Ceribell, Inc.
CeriBell, Inc. has executed a Power of Attorney authorizing company representatives to act on behalf of its officers and directors for SEC filing requirements. This administrative action streamlines the reporting process for future equity transactions and ownership disclosures.…more
$27.15+0.00%vs prev closeView filingShare
43 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 4d agoAfter-hours26.10.21 05:05#●●●#●●●
Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026…more
Medical technology company Ceribell announced it will release its third quarter 2026 financial results after the market close on November 3, 2026. Management will host a conference call to discuss the company's financial performance following the release.…more
$27.15+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.30Pre-market26.09.30 20:00
●●●●●●●● ●●●●● ●●●●●●
Ceribell has received FDA clearance for new software that simplifies real-time brain activity monitoring and trending. This advancement enables faster clinical decision-making for patients across all age groups in critical care settings.…more
$27.15+0.00%vs prev close - 8.10After-hours26.08.11 05:05
●●●●●●●● ●●●●● ●●●●●●
세리벨은 2분기 매출이 전년 동기 대비 33% 증가하며 견조한 성장세를 보였고, 이에 따라 연간 매출 가이던스를 상향 조정했습니다. FDA 승인과 신규 자금 조달을 통해 사업 확장 동력을 확보하며 시장 점유율 확대에 집중하고 있습니다.…more
$27.15+0.00%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report